P108
The human amniotic fluid stem cell secretome as new promising tool to restore cardiac regeneration by paracrine therapy

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

C Balbi

C Balbi

Author

K Lodder

K Lodder

Author

S Moimas

S Moimas

Author

F Moccia

F Moccia

Author

V Rosti

V Rosti

Author

T Van Herwaarden

T Van Herwaarden

Author

M Giacca

M Giacca

Author

M J Goumans

M J Goumans

Author

A M Smits

A M Smits

Author

S Bollini

S Bollini

Author

You may be interested in

Congress Presentation

Extracellular vesicles from second trimester human amniotic fluid as candidate therapeutics against myocardial injury

29 August 2025

Congress Presentation

Effects of pericyte and smooth muscle specific knock-out of CXCL12 on cardiac function after myocardial ischemia in mice

25 August 2023

Congress Presentation

Harnessing novel paracrine factors from the proteomes of cardiac and mesenchymal stem cells to promote repair of the fibrotic heart

21 May 2023

Congress Presentation

Systemic administration of hEPSC-derived Trophoblast stem cells for cardiac regeneration

29 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources